Treatment Action Group

TB LAM testing briefs

Two important tools for activists to use with donors and national TB programs in advocating for increased scale-up of the inexpensive, urine TB LAM test - an essential diagnostic test for TB in people living with HIV.

Read More →

TB CAB statement on M72/AS01E TB vaccine candidate development

Statement by the Global TB Community Advisory Board to the High-level consultation on accelerating the development of the M72/AS01E tuberculosis vaccine candidate

Read More →

TAG statement on FDA priority review of pretomanid

Statement from Treatment Action Group on FDA priority peview of TB Alliance’s new anti-TB drug pretomanid.

Read More →

Advocacy webinar to prioritize TB in 2019 PEPFAR COPs - materials now available online

Treatment Action Group (TAG), AVAC, the Elizabeth Glaser Pediatric AIDS Foundation, Health GAP, IMPAACT4TB, and RESULTS hosted a webinar on 23 January 2019 on how to strategize and engage in PEPFAR Country Operational Plans (COPs) planning to address and strengthen the global response to TB through PEPFAR, and introduced tools to galvanize advocacy efforts.

Read More →

Advocacy webinar to prioritize TB in 2019 PEPFAR COPs

Back by popular demand! As tuberculosis (TB) is the leading global killer of people living with HIV, TB programming must be prioritized and integrated within life-saving bilateral efforts such as PEPFAR. The expected release of the PEPFAR Country Operational Plans (COPs) provides a critical opportunity for advocates to ensure that the latest developments in TB treatment, prevention and diagnostics are implemented within PEPFAR countries.

Read More →

TAGline Fall 2018: Intellectual property and access

Bringing down the House on intellectual property and access

Read More →

New TAG report: Funding for TB research climbed to new high in 2017

Global funding for TB research climbed to a previously unreported high of USD $772 million in 2017.

Read More →

Checklist of essential TB services

A new checklist from Treatment Action Group lays out simply the core elements of an adequate TB response.

Read More →

Reality Check: The Price of Bedaquiline

The "Reality Check" dispels myths that have been circulated among members of the global TB community and used to justify pricing bedaquiline out of the reach of TB programs and patients.

Read More →

An Activist’s Guide to Bedaquiline (Sirturo)

The guide highlights important safety and efficacy data reported thus far and offers advocacy recommendations for activists to take forward.

Read More →

Page 1 of 13 · Total posts: 10

1 2 Last→